Why It Matters
Visiting Nurse Association Health Group Inc. (VNAHG) ended its lobbying relationship with Washington Strategic Consulting Inc. at the close of the first quarter of 2026, according to a Quarter One 2026 LDA filing signed May 27.
The healthcare lobbying termination comes as the home health sector faces ongoing pressure from federal reimbursement cuts. VNAHG, a New Jersey-based nonprofit that serves more than 130,000 patients annually, depends heavily on Medicare and Medicaid reimbursements, making federal payment policy central to its financial stability.
By the Numbers
The VNAHG lobbying activity disclosure listed $5,000 in fees for the quarter, with lobbyist Kyle Mulroy of Washington Strategic Consulting as the sole registered advocate on the account.
Broader Context
The issues at the center of the VNAHG lobbying disclosure, Medicare home health payment policy, funding for federally qualified health centers and the 2026 Home Health Prospective Payment System Final Rule sit in the middle of one of the more contentious health policy fights in Washington right now.
The Centers for Medicare and Medicaid Services has proposed significant reductions to home health reimbursement rates in recent years, and the 2026 Home Health Prospective Payment System (HH PPS) Final Rule has drawn sustained opposition from home health providers, who argue that cuts threaten access to care for elderly and disabled patients who rely on in-home services. For a nonprofit like VNAHG, which derives the bulk of its roughly $47 million in annual revenue from Medicare and Medicaid, these payment rules are not abstract policy debates. They directly affect the organization's ability to operate.
Federally Qualified Health Centers (FQHC) receive direct federal grants through the Health Resources and Services Administration under Section 330 of the Public Health Service Act. VNAHG's inclusion of FQHC funding in its lobbying issues suggests the organization either operates or is affiliated with an FQHC, making Health Resources and Services Administration (HRSA) appropriations a parallel concern alongside Medicare payment rates.
The Bottom Line
With no new lobbying registration identified for VNAHG, it is unclear whether the organization plans to continue federal advocacy through another firm or has pulled back from direct lobbying altogether. Given that Medicare reimbursement policy remains unresolved and the 2026 HH PPS Final Rule is still a live issue, the timing of the lobbying client termination is notable for an organization with this level of federal funding exposure.
Access the Legis1 platform for comprehensive political news, data, and insights.
